Evolution of bone metastases in patients receiving at least three months of checkpoint inhibitors.
- Gefard-Gontier, E, Markich, R, Zysman, M, Veillon, R, Daste, A, Domblides, C et al.. Evolution of bone metastases in patients receiving at least three months of checkpoint inhibitors. Cancer Immunol Immunother. 2022;71 (11):2609-2618. doi: 10.1007/s00262-022-03180-x. PubMed PMID:35305123 .
- Team : Immunology of Cancer and Inflammatory Diseases